Characterisation of candidate human embryonic stem cell processing methods to determine amenability to controllable manufacturing for product supply
Human embryonic stem cells (hESCs) hold great promise for cell-based therapies and drug screening applications given their capability to self-renew and their potential to differentiate into all major lineages of somatic cells in the human body. However, for hESCs to be successfully commercialised we...
| Main Author: | |
|---|---|
| Published: |
Loughborough University
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.647325 |